FDA Drug Application (202996) for LARIN 1.5/30 by NOVAST LABS LTD

Back to FDA Applications sponsored by NOVAST LABS LTD

Application Number202996
Product Number001
FormTABLET;ORAL-21
Dosage0.03MG;1.5MG
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code AB Products meeting necessary bioequivalence requirements
Reference Drug
Drug NameLARIN 1.5/30
Active IngredientETHINYL ESTRADIOL; NORETHINDRONE ACETATE

Active IngredientCount
List of drugs with Active Ingredient ETHINYL ESTRADIOL226
List of drugs with Active Ingredient NORETHINDRONE ACETATE56


Back to FDA Applications sponsored by NOVAST LABS LTD